XML 197 R138.htm IDEA: XBRL DOCUMENT
v3.20.4

Alcon subsidiaries - Equity interests (Details) $ in Millions | 12 Months Ended
--- | ---
Dec. 31, 2020 USD ($)
Disclosure of subsidiaries [line items] |
Total asset and net sales threshold | $ 5
Alcon Laboratorios Argentina S.A. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratories (Australia) Pty Ltd [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Ophthalmika GmbH [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratories Belgium BVBA [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
N.V. Alcon S.A. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Brasil Cuidados com a Saúde Ltda. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Canada Inc. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratorios Chile Ltd. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon (China) Ophthalmic Product Co., Ltd. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Hong Kong Limited [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Laboratorios Alcon de Colombia S.A. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Pharmaceuticals (Czech Republic) s.r.o. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Nordic A/S [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
AlconLab Ecuador S.A. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Laboratoires Alcon S.A.S. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Deutschland GmbH [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
CIBA Vision GmbH [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
WaveLight GmbH [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratories Hellas- Commercial and Industrial S.A. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Hungary Pharmaceuticals Trading Limited Liability Company [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratories (India) Private Limited [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
PT. CIBA Vision Batam [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratories Ireland Limited [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Optonol Ltd. [member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Italia S.p.A. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Japan Ltd. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratories (Malaysia) Sdn. Bhd. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
CIBA Vision Johor Sdn. Bhd. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratorios, S.A. de C.V. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Nederland B.V. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratories (New Zealand) Ltd. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratories (Philippines), Inc. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Pharmaceutical del Peru S.A. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratories (Philippines), Inc. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Polska Sp. z o.o. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Portugal-Produtos e Equipamentos Oftalmológicos Lda. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon (Puerto Rico), Inc. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Romania S.R.L. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Farmacevtika LLC [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Pte Ltd [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Singapore Manufacturing Pte Ltd [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
CIBA Vision Asian Manufacturing and Logistics Pte Ltd. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratories (South Africa) (Pty) Ltd. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Korea Ltd. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Healthcare S.A. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Grieshaber AG [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Management SA [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Pharmaceuticals Ltd. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Services AG [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Switzerland SA [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratories (Thailand) Limited [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratuvarlari Ticaret A.S. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Ukraine LLC [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Eye Care UK Limited [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Finance Corporation [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Laboratories, Inc. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon RefractiveHorizons, LLC [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Research, LLC [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Vision, LLC[Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
CIBA Vision, LLC [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
WaveLight, Inc. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
ClarVista Medical, Inc. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
PowerVision, Inc. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Tear Film Innovations, Inc. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
TrueVision Systems, Inc. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%
Alcon Lensx, Inc. [Member] |
Disclosure of subsidiaries [line items] |
Proportion of voting rights held in subsidiary | 100.00%
Proportion of voting rights held in subsidiary | 100.00%

X
- Definition Total Asset and Net Sales Threshold To Be Included Consolidated Statements + References No definition available. + Details
Name: | alc_TotalAssetandNetSalesThresholdToBeIncludedConsolidatedStatements
Namespace Prefix: | alc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The proportion of the voting rights in a subsidiary held by the entity. [Refer: Subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2020-01-01 -Paragraph 17 -Subparagraph b -Clause iii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2020-en-r&anchor=para_17_b_iii&doctype=Standard -URIDate 2020-01-01 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2020-01-01 -Paragraph 16 -Subparagraph b -Clause iii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2020-en-r&anchor=para_16_b_iii&doctype=Standard -URIDate 2020-01-01 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2020-01-01 -Paragraph 19B -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&anchor=para_19B_c&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_ProportionOfVotingPowerHeldInSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratoriosArgentinaS.A.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratoriesAustraliaPtyLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconOphthalmikaGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratoriesBelgiumBVBAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_N.V.AlconS.A.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconBrasilCuidadosComASadeLtdaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconCanadaInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratoriosChileLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconChinaOphthalmicProductCo.Ltd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconHongKongLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_LaboratoriosAlcondeColombiaS.A.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconPharmaceuticalsCzechRepublics.r.o.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconNordicASMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLabEcuadorS.A.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_LaboratoiresAlconS.A.S.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconDeutschlandGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_CIBAVisionGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_WaveLightGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratoriesHellasSingleMemberCommercialandIndustrialS.A.C.I.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconHungaryPharmaceuticalsTradingLimitedLiabilityCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratoriesIndiaPrivateLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_PT.CIBAVisionBatamMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratoriesIrelandLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_OptonolLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconItaliaS.p.A.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconJapanLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratoriesMalaysiaSdn.Bhd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_CIBAVisionJohorSdn.Bhd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratoriosS.A.deC.V.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconNederlandB.V.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratoriesNewZealandLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconCentroamericaS.A.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconPharmaceuticaldelPeruS.A.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratoriesPhilippinesInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconPolskaSp.zo.o.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconPortugalProdutoseEquipamentosOftalmolgicosLda.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconPuertoRicoInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconRomaniaS.R.L.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconFarmacevtikaLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconPteLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconSingaporeManufacturingPteLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_CIBAVisionAsianManufacturingandLogisticsPteLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratoriesSouthAfricaPtyLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconKoreaLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconHealthcareS.A.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconGrieshaberAGMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconManagementSAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconPharmaceuticalsLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconServicesAGMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconSwitzerlandSAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratoriesThailandLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratuvarlariTicaretA.S.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconUkraineLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconEyeCareUKLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconFinanceCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLaboratoriesInc.fkaAlconUSHoldingsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconRefractiveHorizonsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconResearchLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconVisionLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_CIBAVisionLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_WaveLightInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_ClarVistaMedicalInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_PowerVisionInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_TearFilmInnovationsInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_TrueVisionSystemsInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=alc_AlconLenSxIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |